Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Erythropoiesis01:14

Erythropoiesis

6.5K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.5K
Erythropoiesis01:14

Erythropoiesis

3.9K
3.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Rh Blood Group01:19

Rh Blood Group

4.0K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.0K
Blood Transfusion01:15

Blood Transfusion

2.8K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatic Mutations in Acquired Pure Red Cell Aplasia: Incidence and Implications.

American journal of hematology·2026
Same author

Macrocytes in hemochromatosis: associations of a common finding in a common disease.

The American journal of the medical sciences·2026
Same author

Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations.

The Lancet. Haematology·2025
Same author

Ferritin reference intervals in a population of working-age adults without anemia.

American journal of hematology·2024
Same author

New molecular approaches to "the first molecular disease".

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2024
Same author

Pure red cell aplasia: The second hundred years.

The American journal of the medical sciences·2023
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Pure red cell aplasia.

Robert T Means1

  • 1Office of the Dean, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN.

Blood
|November 25, 2016
PubMed
Summary
This summary is machine-generated.

Pure red cell aplasia (PRCA) is a bone marrow disorder causing severe anemia. Treatment often involves immunosuppression, with Cyclosporine A being highly effective for various PRCA subtypes.

More Related Videos

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.5K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 11, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
11:31

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

18.5K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

1.1K

Area of Science:

  • Hematology
  • Immunology
  • Internal Medicine

Background:

  • Pure red cell aplasia (PRCA) is characterized by anemia, low reticulocytes, and absent erythroid precursors in bone marrow.
  • PRCA can be congenital (Diamond-Blackfan anemia) or acquired, presenting as a primary autoimmune condition or secondary to other diseases.
  • Acquired PRCA has diverse causes, including autoimmune disorders, infections (B19 parvovirus), lymphoproliferative diseases, thymoma, and drug toxicity.

Purpose of the Study:

  • To provide a comprehensive overview of Pure Red Cell Aplasia (PRCA).
  • To discuss the various etiologies and clinical presentations of PRCA.
  • To outline current therapeutic strategies for PRCA, emphasizing effective treatments.

Main Methods:

  • Literature review of PRCA.
  • Analysis of diagnostic criteria for PRCA.
  • Evaluation of treatment outcomes for different PRCA subtypes.

Main Results:

  • PRCA is defined by specific hematologic and bone marrow findings.
  • Primary acquired PRCA is often antibody-mediated autoimmune.
  • Secondary PRCA is linked to a wide range of conditions and agents.

Conclusions:

  • PRCA management requires identifying the underlying cause.
  • Immunosuppression is a key therapeutic approach for PRCA.
  • Cyclosporine A, often with corticosteroids, is the most effective immunosuppressive agent for PRCA.